Drug-eluting stentsCitationsMoses JW, et al. (2003). Sirolimus-eluting stents
versus standard stents in patients with stenosis in a native coronary artery.
New England Journal of Medicine, 349(14):
1315–1323. Stone GW, et al. (2004). A polymer-based,
paclitaxel-eluting stent in patients with coronary artery disease.
New England Journal of Medicine, 350(3):
221–231. Tanabe K, et al. (2003). TAXUS III trial: In-stent
restenosis treated with stent-based delivery of paclitaxel incorporated in a
slow-release polymer formulation. Circulation, 107(4):
559–564.
| | Author: | Douglas Dana Robin Parks, MS | Last Updated: August 15, 2007 | | Medical Review: | Anne C. Poinier, MD - Internal Medicine Caroline S. Rhoads, MD - Internal Medicine Stephen Fort, MD, MRCP, FRCPC - Interventional Cardiology | © 1995-2008 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.
| 
| |
| |